Luminex Corp (Luminex) develops, manufactures and markets proprietary biological testing technologies. The company offers a wide range of products including assays, instruments, reagents and accessories, software and replacement parts. It employs proprietary technologies to test for proteins and nucleic acids, and to serve multiplexing, precision, sensitivity, accuracy, and for reduction of labor. Luminex offers its products to various markets such as pharmaceutical drug discovery; clinical diagnostics; biomedical research including personalized medicine and genomic research. The company sells its products through a direct sales channel and strategic distribution partners in Asia-Pacific North America and Europe. Luminex is headquartered in Texas, the US.
Headquarters
United States of America
Address
12212 Technology Blvd, 512-219-8020, Austin, Texas, 78727
Website
www.luminexcorp.com
Telephone
1 512 2494741
No of Employees
1,325
Industry
Medical Equipment
Revenue (2020)
$417.4M
Products and Services
| Products | Brands |
|---|---|
| Instruments: | Brands: |
| Aries and Aries M1 Systems | Amnis |
| Luminex 100/200 | ARIES |
| XXX | XXX |
| XXX | XXX |
| XXX | XXX |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2021 | Contracts/Agreements | In November, the company secured a US$48 million contract from the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania under solicitation SPE2DH-16-R-0002 for medical equipment and accessories for the Defense Logistics Agency Electronic Catalog. |
| 2021 | Ownership Changes | In July, the company was acquired by DiaSorin SpA, a biotechnology company for US$1.8 billion. |
| 2021 | Regulatory Approval | In March, the company's NxTAG respiratory pathogen panel (RPP) test has received emergency use authorization from the US FDA for respiratory infection testing, and SARS-CoV-2. |
Competitor Comparison
| Key Parameters | Luminex Corp | Becton Dickinson and Co | Roche Diagnostics International Ltd | Hologic Inc | PerkinElmer Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | Switzerland | United States of America | United States of America |
| City | Austin | Franklin Lakes | Rotkreuz | Marlborough | Waltham |
| State/Province | Texas | New Jersey | Zug | Massachusetts | Massachusetts |
| No. of Employees | 1,325 | 75,000 | 2,600 | 6,705 | 16,700 |
| Entity Type | Private | Public | Private | Public | Public |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Nachum Shamir | President; Chief Executive Officer; Chairman | Executive Board | 2020 | 67 |
| Harriss T. Currie | Senior Vice President - Finance; Chief Financial Officer; Treasurer | Senior Management | 2013 | 59 |
| Richard W. Rew II | Secretary; Senior Vice President; Chief Compliance Officer; General Counsel | Senior Management | 2015 | 53 |
| Joern Mosner, Ph.D. | Vice President - Assay Research and Development & Clinical Affairs | Senior Management | 2019 | - |
| David Bourne | Vice President - Business Development and Strategic Planning | Senior Management | 2015 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2022 | XX |
| Non Dignissim Eros | Proin vel | Convallis | 2022 | XX |
| Non Dignissim Eros | Proin vel | Convallis | 2022 | XX |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer